Stem announces Q4 and full year 2025 results, achieving first-ever positive Adjusted EBITDA with record margins ...
Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results